Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
GLP-1-receptoragonisten verlagen mogelijk het risico op epilepsie bij DM2
mrt 2026 | Diabetes, Epilepsie